Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000725142 | SCV000334418 | uncertain significance | not provided | 2017-02-28 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000725142 | SCV000577413 | likely benign | not provided | 2020-03-27 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000534113 | SCV000650276 | uncertain significance | Epidermolysis bullosa simplex 5B, with muscular dystrophy; Epidermolysis bullosa simplex, Ogna type; Epidermolysis bullosa simplex 5C, with pyloric atresia; Autosomal recessive limb-girdle muscular dystrophy type 2Q; Epidermolysis bullosa simplex with nail dystrophy | 2023-12-07 | criteria provided, single submitter | clinical testing | This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 1478 of the PLEC protein (p.Glu1478Lys). This variant is present in population databases (no rsID available, gnomAD 0.1%), including at least one homozygous and/or hemizygous individual. This missense change has been observed in individual(s) with clinical features of limb-girdle muscular dystrophy (Invitae). ClinVar contains an entry for this variant (Variation ID: 282780). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ce |
RCV000725142 | SCV001248535 | likely benign | not provided | 2023-01-01 | criteria provided, single submitter | clinical testing | PLEC: BS2 |
MGZ Medical Genetics Center | RCV002288959 | SCV002580793 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2Q | 2022-03-14 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000725142 | SCV003817343 | uncertain significance | not provided | 2023-09-06 | criteria provided, single submitter | clinical testing |